A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2011
11/30/2011	CN102258598A 以木瓜有效部位制成的药物、其制备方法及其应用 Drugs effective parts made of papaya, their preparation and their use
11/30/2011	CN102258591A 祛湿除痹通络胶囊 Dampness chubi Capsules
11/30/2011	CN102258589A 一种用于治疗风湿性关节炎的鹿血药酒 Deer blood wine for the treatment of rheumatoid arthritis
11/30/2011	CN102258586A 一种治疗类风湿性关节炎的组合物 Composition for the treatment of rheumatoid arthritis
11/30/2011	CN102258575A 一种治疗肩周炎的膏药及其制备方法 A frozen treat plaster and its preparation method
11/30/2011	CN102258560A 一种治疗关节炎的药膏 A method of treating arthritis ointment
11/30/2011	CN102258514A 金松双黄酮在制备防治骨质疏松的药物和食品中的应用 Jinsong biflavone prevention of osteoporosis in the manufacture of drugs and food
11/30/2011	CN102258479A 一种骨钙素的注射用缓释微球制剂 One kind of osteocalcin injectable sustained release microsphere preparation
11/30/2011	CN102258475A 黄豆苷元固体脂质纳米粒及其制备方法 Daidzein solid lipid nanoparticles and its preparation method
11/30/2011	CN102008584B 一种治疗寒凝气滞型痛经的药物 A method of treating dysmenorrhea Hanning Qi stagnation drugs
11/30/2011	CN101919860B 一种含有己酮可可碱和双氯芬酸的药物组合物及其用途 Containing pentoxifylline and diclofenac in pharmaceutical compositions and uses
11/30/2011	CN101879262B 一种治疗股骨头坏死的中药组合物 A treatment for osteonecrosis of the herbal composition
11/30/2011	CN101850042B 一种治疗骨折的药物 A fracture of the medication
11/30/2011	CN101843801B 一种透骨活血止痛酊 One kind Speranskia Huoxuezhitong tincture
11/30/2011	CN101716141B 一种氟罗沙星注射液及其制备方法 An injection Fleroxacin fluoride and its preparation method
11/30/2011	CN101305777B 银杏果肉酱 Ginkgo fruit sauce
11/30/2011	CN101156911B 一种治疗风湿、类风湿性关节炎的中药酒 A treatment for rheumatism, arthritis of wine
11/29/2011	US8068580 Methods and devices for quantitative analysis of x-ray images
11/29/2011	US8067674 Desaturase genes, enzymes encoded thereby, and uses thereof
11/29/2011	US8067575 RNA interference mediated inhibition of cyclin D1 gene expression using short interfering nucleic acid (siNA)
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067388 Decoy-containing pharmaceutical compositions and method of using the same
11/29/2011	US8067376 Pharmaceutical compositions for transdermal delivery
11/29/2011	CA2672000C Methods and compositions using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for treatment and management of lymphoma
11/29/2011	CA2658359C Heterocyclic compounds and methods of use
11/29/2011	CA2494345C Combination of an aromatase inhibitor with a bisphosphonate
11/29/2011	CA2494302C Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
11/29/2011	CA2486910C Ophthalmological use of roflumilast for the treatment of diseases of the eye
11/29/2011	CA2478645C Treatment of central nervous system damage
11/29/2011	CA2473634C 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
11/29/2011	CA2465757C Triazole derivatives as cyclooxygenase (cox) inhibitors
11/29/2011	CA2449356C Process for preparing granular compositions
11/29/2011	CA2401241C 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
11/28/2011	CA2738045A1 Conjugate compounds, methods of making same, and uses thereof
11/24/2011	WO2011145777A1 Pharmaceutical composition including an hif-2α inhibitor as an active ingredient for preventing or treating arthritis
11/24/2011	WO2011144994A1 Pharmaceutical compositions of nsaid and acid inhibitor
11/24/2011	WO2011144785A1 Use of poloxamines as inducers of the osteogenic differentiation of mesenchymal cells
11/24/2011	WO2011144761A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
11/24/2011	WO2011144584A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/24/2011	WO2011144517A1 Furin and biologically active derivatives thereof for use in the prevention or treatment of an inflammatory disease
11/24/2011	WO2011084513A3 Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
11/24/2011	WO2011080651A3 Polymorphic forms of febuxostat
11/24/2011	WO2011052950A3 Pharmaceutical composition comprising indole compound
11/24/2011	US20110289608 Antisense modulation of interleukins 17 and 23 signaling
11/24/2011	US20110289605 Animal Model for Osteoarthritis and Intervertebral Disc Disease
11/24/2011	US20110288275 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/24/2011	US20110288176 Ethacrynic acid-containing composition for prevention or treatment of transglutaminase-related diseases and method for prevention or treatment of transglutaminase-related diseases using the same
11/24/2011	US20110288161 Methods for treatment of thiol-containing compound deficient conditions
11/24/2011	US20110288158 Methods and compositions for the specific inhibition of gene expression by double-stranded rna
11/24/2011	US20110288156 Nucleic Acids, Polypetides, and Methods for Modulating Apoptosis
11/24/2011	US20110288147 Compositions and methods for the specific inhibition of gene expression by DSRNA containing a tetraloop
11/24/2011	US20110288142 CRYSTALLINE N--5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-thiophenecarboxamide hydrochloride
11/24/2011	US20110288122 Pharmaceutical Compositions and Administrations Thereof
11/24/2011	US20110288095 Thiophene-carboxamides useful as inhibitors of protein kinases
11/24/2011	US20110288093 Compounds, Compositions, and Methods Comprising Pyridazine Sulfonamide Derivatives
11/24/2011	US20110288088 Substituted pyrrolo-pyrazole derivatives active as kinase inhibitors
11/24/2011	US20110288083 Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
11/24/2011	US20110288081 Pyrimidine compounds and uses thereof
11/24/2011	US20110288077 Compounds for the treatment of inflammatory diseases
11/24/2011	US20110288068 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/24/2011	US20110288067 Pyrrolopyrazine Kinase Inhibitors
11/24/2011	US20110288060 apparatus and process for producing crystals
11/24/2011	US20110288056 Once daily formulations of tetracyclines
11/24/2011	US20110288051 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
11/24/2011	US20110288048 Promoter for hard tissue formation
11/24/2011	US20110288037 Pharmaceutical Composition for the Treatment of Pathologies Caused by the General Response of the Immune System
11/24/2011	US20110288025 Biopolymer produced by fermenting the extract of soybean with folic acid and a composition containing thereof
11/24/2011	US20110288024 Compositions and Methods for Treating Arthritis and/or Diseases Involving Cartilage Degeneration
11/24/2011	US20110288004 Viral Sequences and Uses Thereof
11/24/2011	US20110287466 Aggregate-Free Urate Oxidase for Preparation of Non-Immunogenic Polymer Conjugates
11/24/2011	US20110287420 Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or WNT
11/24/2011	US20110287117 Adjuvant Therapy in the Treatment of Gouty Arthritis
11/24/2011	US20110287111 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds
11/24/2011	US20110287107 Porous bioceramic composition for bone repair
11/24/2011	US20110287088 Modulation of olfml-3 mediated angiogenesis
11/24/2011	US20110287079 Supporting material for cell sheet
11/24/2011	US20110287070 Bone repair material and method for producing the same
11/24/2011	US20110287067 Reinforced adhesive complex coacervates and methods of making and using thereof
11/24/2011	US20110287063 Methods for prevention and treatment of inflammation using anti-chemokine antibodies
11/24/2011	US20110287049 Prevention and treatment of amyloidogenic diseases
11/24/2011	US20110287040 Materials and methods for treatment of inflammation
11/24/2011	US20110287032 Novel ctla4-ig immunoadhesins
11/24/2011	US20110287031 Covalently reactive transition state analogs and methods of use thereof
11/24/2011	US20110287023 High Affinity Antibodies Against HMGB1 and Methods of Use Thereof
11/24/2011	US20110287022 Interferon alpha-induced pharmacodynamic markers
11/24/2011	US20110286990 Methods of diagnosing and treating fibrosis
11/24/2011	US20110286939 Osteogenic compositions containing a coloring agent
11/24/2011	US20110286923 Novel conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
11/24/2011	US20110286918 Immunotherapy of autoimmune disorders using antibodies which target b-cells
11/24/2011	CA2800018A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
11/24/2011	CA2798970A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
11/23/2011	EP2388265A1 Compositions and methods for the treatment of immune related diseases
11/23/2011	EP2387573A1 6-phenyl-lh-imidazo ý4, 5-c¨pyridine-4-carbonitrile derivatives as cathepsin s and/or cathepsin k inhibitors
11/23/2011	EP2387412A1 Methods for increasing adiponectin
11/23/2011	EP2377926A9 Chondrocyte-like cell, and method for producing same
11/23/2011	EP2260033B1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
11/23/2011	EP1915140B1 Novel use of peptide compounds for treating muscle pain
11/23/2011	EP1735277B1 2-alkylidene-18,19-dinor-vitamin d compounds
11/23/2011	EP1569937B1 C-6 modified indazolylpyrrolotriazines
11/23/2011	EP1492780B1 5-substituted 1,1-dioxo-¬1,2,5 thiazolidine-3-one derivatives as ptpase 1b inhibitors

1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 820